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Nuclear Shuttling of Yeast Scaffold Ste5
Is Required for Its Recruitment to the Plasma
Membrane and Activation of the Mating MAPK Cascade
al., 1998). Pheromone binds a cell surface receptor that
activates a heterotrimeric G protein by releasing an in-
hibitory Ga subunit (Gpa1) from a Gbg (Ste4/Ste18) di-
mer. Gb transduces the signal to a MAP kinase (MAPK)
cascade by binding to Ste20, a MAPKKKK that localizes
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Boston, Massachusetts 02115 at the cell cortex at sites of morphogenesis. Ste20 then
activates MAPKKK Ste11, which activates MAPKK Ste7,
which activates MAPKs Fus3 and Kss1, of which Fus3
Summary is most critical. MAPK activation leads to the activation
of many genes (e.g., FUS1), G1 arrest, and morphogene-
Localization of Ste5 to Gb at the plasma membrane sis, resulting in pear-shaped cells termed shmoos that
is essential for transmission of the pheromone signal can fuse with partner cells.
to associated MAP kinase cascade enzymes. Here, The Ste5 scaffold is crucial for the function of the
we show that this crucial localization requires prior MAPK cascade enzymes in vivo (Choi et al., 1994; Kranz
shuttling of Ste5 through the nucleus. Ste5 shuttles et al., 1994), although the kinases can phosphorylate one
through the nucleus constitutively during vegetative another in vitro (Errede et al., 1993; Neiman and Her-
growth. Pheromone enhances nuclear export of Ste5, skowitz, 1994; Wu et al., 1995). In the absence and pres-
and this pool translocates vectorially to the cell periph- ence of pheromone, Ste5 tethers Ste11, Ste7, and Fus3
ery. Remarkably, Ste5 that cannot transit the nucleus into a high molecular weight complex (Choi et al., 1994,
is unable to localize at the periphery and activate the 1999; Kranz et al., 1994). In response to pheromone,
pathway, while Ste5 with enhanced transit through Ste5 binds to free Gb (Feng et al., 1998) through a RING-
the nucleus has enhanced ability to localize to the H2 domain (Whiteway et al., 1995; Inouye et al., 1997;
periphery and activate the pathway. This novel regula- Feng et al., 1998), allowing Ste11 to be activated (Feng
tory scheme may ensure that cytoplasmic Ste5 does et al., 1998). Gb appears to serve a recruitment function
not activate downstream kinases in the absence of for Ste5, because artificially targeting Ste5 to the plasma
pheromone and could be applicable to other mem- membrane causes constitutive activation of the pathway
brane-recruited signaling proteins. and bypasses the requirement for Gb but not Ste20
(Pryciak and Huntress, 1998). The localization of overex-
pressed Ste5-GFP fusions suggests that Ste5 is cyto-
Introduction plasmic and accumulates at the cell surface of emerging
shmoos (Pryciak and Huntress, 1998). However, no evi-
The recruitment of cytoplasmic signaling proteins to the dence exists for rapid membrane association that would
plasma membrane in response to an extracellular signal be required for an initial signaling event.
is an essential step in the activation of protein kinase
Previous studies raised the possibility that cells need
cascades. For example, the activation of Raf at the
to prevent Ste5 from being recruited to the plasma
plasma membrane occurs through its association with
membrane and activating the kinases in the absence of
Ras at the plasma membrane (Leevers et al., 1994;
pheromone. First, Ste5 has a rate-limiting role in theStokoe et al., 1994). Protein kinase C isozymes also
activation of the MAPK cascade that does not requiretranslocate from the cytoplasm to the cell periphery
pheromone (Choi et al., 1994; Kranz et al., 1994). Second,by binding to anchoring proteins (Mochly-Rosen, 1995).
Ste5 appears to insulate the associated kinases duringMany other cytoplasmic scaffolding and adaptor pro-
vegetative growth to prevent cross-talk (Yashar et al.,teins that link signaling enzymes also appear to localize
1995; Lee and Elion, submitted). This may be importantto the periphery in order to transmit signals received
because Ste20, Ste11, Ste7, and Kss1 also function inacross the plasma membrane (Faux and Scott, 1996;
other signal transduction pathways in yeast that re-Elion, 1998; Zuker and Ranganathan, 1999). While it is
spond to distinct extracellular signals (Roberts and Fink,clear that proper targeting of cytoplasmic signaling
1994; Posas and Saito, 1997) as well as during normalcomponents is an essential feature of signal transmis-
vegetative growth (Lee and Elion, submitted).sion, little is known about the mechanisms that ensure
In this report, we show that cytoplasmic Ste5 localizesthat these signaling components are (1) targeted to the
to the cell periphery by a mechanism that is rapid, inde-plasma membrane at the right time and (2) prevented
pendent of ongoing protein synthesis, and regulated byfrom misactivating signal transduction pathways in the
pheromone. Surprisingly, Ste5 also shuttles through theabsence of the appropriate signal.
nucleus, and several lines of evidence indicate that theThe S. cerevisiae mating pathway provides a good
nuclear shuttling is required for Ste5 to localize to Gbsystem for studying how an extracellular signal activates
and activate the downstream kinases. Our results arguea protein kinase cascade (Gustin et al., 1998; Leeuw et
that haploid yeast cells use a regulated sorting mecha-
nism through the nucleus to target Ste5 to the plasma
membrane and prevent recruitment of cytoplasmic Ste5* To whom correspondence should be addressed (e-mail: elion@
bcmp.med.harvard.edu). in the absence of pheromone.
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Figure 1. Localization of Ste5
(A) Immunoblot of Ste5-Myc9 constructs. Lane 1, STE5-MYC9 CEN; lane 2, STE5-MYC9 2m; lane 3, STE5 CEN; lanes 4 and 5, CUP1p-STE5-
MYC9 CEN 2/1 Cu21; lanes 6 and 7, STE5-MYC9 CEN 2/1 a F. The blot was probed with 9E10 antibody and reprobed with Tcm1 antibody.
(B) Ste5-GFP expressed from the STE5 promoter.
(C) Ste5-GFP expressed from the CUP1 promoter.
(D±F) Indirect immunofluorescence of Ste5-Myc9. (D) CUP1-STE5-MYC9 CEN 6 a F, (E) STE5 CEN 2a F. Comparable exposure times are
shown for (D) and (E). (F) STE5-MYC9 2m 2a F. Unbudded cells (z62%) showed nuclear staining 2a F versus z17% after 10 min in 50 nM
a F (n 5 200).
(G) a factor induces rapid nuclear to cytoplasmic shift in Ste5-Myc9. PY1236 (cdc28-4) with STE5-MYC9 2m was grown to midlogarithmic
phase at 258C, diluted to an A600 of 0.3, and shifted to 378C for 3 hr. Cells were pelleted and resuspended in 378C media (SC-ura [pH 4.5])
with 10 mg/ml of cycloheximide for 10 min, then incubated 6 5 mM a factor for 10 min at 378C. Similar results were found after 5 min a factor
induction.
For (A)±(F), constructs were expressed in EY1775 (MATa bar1 ste5D) and cells were grown to an A600 of 0.5±0.8, then incubated 6 50 nM a
factor for 1.5 hr (or grown in medium containing 500 mM CuSO4 for 2 hr prior to a factor induction for CUP1 plasmids). (B) is visualized with
a Nikon epi-fluorescence microscope attached to a CH250/KAF-1400 liquid cooled CCD camera (Photometrics, AZ) and a metamorph imaging
system (Universal Imaging, PA). (C)±(G) and Figures 2±7 were visualized with a Zeiss Axioscope attached to a 3 CCD camera (Toshiba, JN)
and Image-Pro Plus windows software 3.0.1 (Media Cybernetics, MD). Arrows point to shmoo tips showing accumulation of Ste5.
Results throughout the cytoplasm and was excluded from the
vacuole (Figures 1B±1D). In the presence of a factor,
Ste5 was still cytoplasmic, but a fraction transiently con-A Nuclear Pool of Ste5 Is Exported to the Cytoplasm
in Response to Pheromone centrated at the tips of emerging projections, being most
evident after z60 min and declining to undetectableTo study the localization of Ste5 at close to native levels
of expression, we made functional green fluorescent levels by 2.5 hr. In addition, the level of Ste5 in the
cytoplasm appeared to be greater.protein (GFP) (Kahana et al., 1995) and Myc-tagged Ste5
fusions (Ste5-GFP and Ste5-Myc9) that were expressed Ste5 was also detected in the nucleus of occasional
cells (Figure 1D, arrow and Figure 1C, inset). When over-from low-copy CEN plasmids with either the STE5 pro-
moter or the CUP1 promoter, which slightly increases expressed from a high-copy 2m plasmid, Ste5-Myc9 was
readily detected in the nucleus of many cells, particularlythe level of Ste5 in the presence of Cu21 (Figure 1A).
In mitotically dividing cells, Ste5 localized diffusely those in G1 phase (Figures 1A and 1F). These results
Ste5 Travels through the Nucleus to Get to Gb
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Figure 2. Ste5 Accumulates in the Nuclei of ste21 Cells
CUP1-STE5-MYC9 CEN in (A) STE21 (EY699), (B) ste21 (PAY20), (C) ste21 treated with cycloheximide, (D) ste5C180A-MYC9 CEN in ste21, (E)
CUP1-ste5D49±66-MYC9 CEN in ste21. Arrows indicate Ste5 at the cell periphery. One hundred percent of cells exhibiting peripheral staining
were unbudded (170 cells scored, of which 36% were unbudded). Similar exposure times are shown. For (A), (B), (D), and (E), cells were grown
in copper containing medium for 2 hr at 308C, then incubated 6 10 mg/ml cycloheximide (CHX) for 10 min, then incubated 6 5 mM a factor
for 10 min. (F) Excess Ste5 suppresses ste21 signal transduction defects. b-galactosidase activity in STE21 (EY699) and ste21D (PAY20)
strains harboring FUS1-lacZ 2m (pJB207) and either STE5 2m (pSKM20) or 2m (YEplac195) after 90 min a factor induction. The average 6 SD
of three transformants is shown.
suggest that a pool of Ste5 is in the nucleus during is allelic to MSN5 (Matheos et al., 1997), regulates the
nuclear localization of Ste5. Ste21 acts at or near thevegetative growth, but that the nuclear pool can only
be detected when it is elevated to a level above that of Gb step of the pathway (Akada et al., 1996), is an im-
portin b-like protein that binds Ran (Gorlich et al., 1997),the cytoplasmic pool.
By contrast, nuclear Ste5 was more rarely detected and is an export receptor for Pho4 (Kaffman et al., 1998).
Ste5-Myc9 expressed at low levels from the CUP1 pro-after a factor induction (Figure 1 legend), suggesting
that a factor triggers its export. We therefore examined moter was predominantly nuclear in all of the ste21 cells,
contrasting sharply with its cytoplasmic localization inthe effect of a factor on the nuclear distribution of Ste5
in the presence of cycloheximide to block de novo syn- control cells (Figures 2A and 2B, 2a F). Treatment with
a factor induced a rapid (within 5 min) shift of Ste5 fromthesis of Ste5. Cells were first synchronized at the a
factor arrest point in G1 phase with a cdc28-4 mutation the nucleus to the cytoplasm of ste21 cells (Figures 2A
and 2B, 1a F). This redistribution was more apparantto ensure uniform effects of a factor. Under these condi-
tions, nuclear Ste5 was detected in 97% of the cells in cells pretreated with cycloheximide, conditions which
appeared to reduce the cytoplasmic pool (Figure 2C).(Figure 1G). Strikingly, a factor induced a rapid (within
5 min) change in Ste5 distribution from obviously nuclear A significant fraction of nuclear Ste5 was still detected
in some ste21 cells, indicating that nuclear export ofto strongly cytoplasmic in 91% of the cells. This redistri-
bution was not due to a change in Ste5 levels (Figure Ste5 is less efficient in the absence of Ste21. These
results argue that Ste5 shuttles in and out of the nucleus1A, lanes 6 and 7), suggesting that a factor induces
rapid export of Ste5 from the nucleus. during vegetative growth and undergoes enhanced ex-
port from the nucleus in the presence of a factor.
The block in Ste5 export in the ste21 mutant wasSte5 Shuttles through the Nucleus by a Mechanism
Involving the Ste21 Export Receptor specific, as mutations in other b-importin-like proteins
(such as CSE1, NMD5, SXM1, LOS1, and MTR10) did notThe fact that nuclear Ste5 was more readily detected
when overexpressed suggested Ste5 normally shuttles cause nuclear accumulation of Ste5 (data not shown).
In addition, the ste21 strain had a partial block in athrough the nucleus. We tested whether STE21, which
Cell
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Figure 3. Localization of Mutant Ste5 Proteins
(A±C) Ste5C180A and Ste5D49±66 do not localize at the shmoo tip in STE5 cells that can signal. (A) Vegetatively growing cells. (B) Cells
induced with a factor. (C) Shmoos visualized by confocal microscopy with a multiphoton laser confocal microscope (BioRad 1024) and 052
Software (BioRad). The EY957 cells expressing CUP1-STE5-MYC9 CEN, CUP1-ste5D49±66-MYC9 CEN, or ste5C180A-MYC9 CEN were
prepared as in Figure 1D. Arrows indicate Ste5 at the shmoo tip.
(D and E) Ste5 derivatives that localize either in the cytoplasm or nucleus are nonfunctional. (D) TAgNLS-Ste5-Myc9 and Ste5D49±66-Myc9.
EY1775 (ste5D) with TAgNLS-STE5-MYC9 2m or ste5D49±66-MYC9 2m were grown to midlogarithmic phase and prepared as in Figure 1D. (E)
Fus1-lacZ levels. b-galactosidase activity assayed in EY1775 (ste5D) with FUS1-lacZ 2m (pJB207) and either CEN, STE5 CEN, TAgNLS-STE5
CEN, or ste5D49±66 CEN 6 50 nM a factor for 1.5 hr.
factor±induced pathway activation that could be com- Ste5 was recruited to the periphery by binding to Gb,
because Ste5C180A, which is defective in binding to Gbpletely bypassed by overexpression of Ste5, as as-
sessed by Fus1-lacZ activity (Figure 3E), G1 arrest, and completely blocked for signal transduction (Feng
et al., 1998), did not localize to the periphery after shortshmoo formation, and mating (data not shown). These
results suggest that the ste21 signal transduction de- or long a factor induction, although it could enter the
nucleus and be exported (Figures 2D and 3B). Ste5 alsofects are due to the partial block in Ste5 export and that
Ste21 directly or indirectly regulates the export of Ste5 rapidly localized to the cell periphery in ste21 mutants
that retained most of Ste5 in the nucleus prior to ain parallel with other regulators in the absence and pres-
ence of a factor. factor treatment (Figure 2B), even when the cells were
pretreated with cycloheximide and appeared to have
lower levels of the cytoplasmic pool (Figure 2C). Collec-Pheromone Induces Rapid Translocation of Ste5
to the Cell Periphery tively, these findings raised the possibility that a factor
induces rapid export of a nuclear pool of Ste5 that local-In the course of our experiments, we noticed that a
small fraction of Ste5 rapidly concentrated at the cell izes to Gb at the plasma membrane.
periphery within 5 min of a factor treatment (Figure 2A,
arrow). This localization was only detected in unbudded Targeting Ste5 to Either the Cytoplasm or the
Nucleus Blocks Signal Transductioncells and was always asymmetric, with Ste5 concen-
trated on one side of the cell (Figure 2 legend). Time To determine the function of nuclear shuttling of Ste5,
we engineered Ste5 proteins that localized either in thecourse analysis of mixed populations of cells showed
that Ste5 always concentrated at the emerging projec- cytoplasm or the nucleus, but not in both compartments.
We restricted Ste5 to the cytoplasm by identifying a nu-tion tip, suggesting that a factor rapidly induces polar-
ized localization of Ste5 to the plasma membrane to the clear localization sequence and deleting this sequence
from the protein. An 18-residue sequence resemblingregion that ultimately elongates to form the projection.
Ste5 Travels through the Nucleus to Get to Gb
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a bipartite nuclear localization sequence (residues 2E, Ste5D49±66-Myc9 could not be detected at the cell
49KKWTEKLARFQRSSAKKK66) was found to be essential periphery after a 10 min a factor treatment in G1 cells,
for nuclear localization of Ste5. Ste5D49±66-Myc9 was nor could it be detected at the projection tips of shmoos
strictly cytoplasmic and excluded from wild-type nuclei after longer a factor treatment (Figure 3B), even with
(Figure 3D) and did not accumulate in the nuclei of ste21 the aid of confocal microscopy (Figure 3C). Thus,
cells (Figure 2E). Ste5 was targeted to the nucleus by Ste5D49±66 behaves like the Ste5C180A mutant that
adding the TAgNLS (MPKKKRKVHMGS; NLS is in boldface; is specifically defective in binding to Gb, although it
Kalderon et al., 1984) to its amino terminus (Figure 3D). displays a wild-type ability to associate with Gb in vitro.
Strains expressing TAgNLS-Ste5 or Ste5D49±66 in Because Ste5 constitutively activates the MAPK cascade
place of Ste5 were defective in a factor±dependent sig- when it is targeted to the plasma membrane by a carboxyl-
nal transduction. FUS1-lacZ expression was reduced to terminal transmembrane sequence (CTM) (Pryciak and
z20% wild-type levels in the TAgNLS-STE5 strain and Huntress, 1998), we tested whether the same CTM could
z0.1% wild-type levels in the ste5D49±66-MYC9 strain restore function to Ste5D49±66. Ste5D49±66-CTM con-
(Figure 3E), and neither strain could promote G1 arrest. stitutively activated the mating MAPK cascade as well
TAgNLS-Ste5 efficiently interacts with Gb, Ste5, Ste11, as Ste5-CTM as assessed by G1 arrest, shmoo forma-
Ste7, Fus3, Kss1, and Bem1 in two hybrid tests (Choi tion, and Fus1-lacZ activity (Figures 5A and 5B and leg-
et al., 1994; Kranz et al., 1994; Lyons et al., 1996; Feng end). Pathway activation was not due to transit through
et al., 1998), and its overexpression leads to more of it the nucleus, because neither protein was detected in
in the cytoplasm and wild-type levels of signal transduc- the nuclei of wild-type or ste21 cells. Thus, the sole
tion (data not shown). Thus, the loss of function of signaling defect of Ste5D49±66 is an inability to localize
TAgNLS-Ste5 is most likely because little of the protein to Gb (Ste4) at the plasma membrane.
is available to bind Gb at the plasma membrane.
Nuclear Localization of Ste5 Correlates
Ste5D49±66 Is Blocked at the Gb Step of the with the Ability to Activate Fus3
Pathway Although It Binds Gb In Vitro The behavior of Ste5D49±66 suggested that shuttling of
By contrast, the complete absence of function for Ste5 through the nucleus, rather than the maintenance
Ste5D49±66 was very surprising, given that this protein of a nuclear pool of Ste5, is required for activation of
is in the cytoplasm and theoretically capable of binding the mating MAPK cascade. We tested this hypothesis
to Gb. It was possible that nuclear Ste5 was required by determining whether coexpression of TAgNLS-Ste5
for Ste12 to activate transcription of mating-specific with Ste5D49±66 could restore wild-type levels of signal
genes, such as STE2, STE4, and FUS3. However, over- transduction. As shown in Figures 5C and 5D, coexpres-
expression of Ste12, which activates mating-specific sion of TAgNLS-Ste5 with Ste5D49±66 did not restore
genes in a ste5 deletion mutant (Elion et al., 1991), did signal transduction. Indeed, Ste5D49±66 inhibited the
not bypass the mating and G1 arrest blocks of the ability of TAgNLS-Ste5 to activate the MAPK cascade
ste5D49±66 strain, arguing against this possibility. An- (compare Fus1-lacZ activity for TAgNLS-Ste5 and TAgNLS-
other trivial explanation was that the D49±66 mutation Ste5 1 Ste5D49±66, 1 a factor), most likely as a result
rendered the protein unable to bind to Gb (Ste4), Ste11, of binding to Ste11, Ste7, and Fus3 in the cytoplasm
Ste7, Fus3, or itself. However, Ste5D49±66 efficiently and sequestering them away from the minor cyto-
oligomerized and associated with free Ste4 as well as plasmic pool of TAgNLS-Ste5. This result argues that the
with Ste11, Ste7, and Fus3 in stringent coprecipitation signaling defect of Ste5D49±66 is due to the loss of its
tests in which Ste5D49±66-Myc9 was expressed at low
ability to shuttle through the nucleus.
levels (Figures 4A±4E). Thus, the signaling defect of
We next tested whether there was a correlation be-
Ste5D49±66 was not due to a block in binding to these
tween the ability of Ste5 to transit the nucleus and acti-signaling components.
vate MAPK Fus3, by constructing three mutant Ste5Despite a normal ability to associate with Gb in vitro
proteins with increasing numbers of lysine to alanine(Figure 4A), genetic suppression tests showed that
substitutions across the sequence required for nuclearSte5D49±66 was blocked at the Gb step of the pathway
localization (i.e., K49±50→A49±50, K64±66→A64±66, andthat is critical for the activation of Ste11 by Ste20. Over-
K49±50K64±66→A49±50A64±66) and testing them forexpression of Gb, Ste20, and Ste50 failed to restore
their ability to enter the nucleus and activate Fus3.mating to the ste5D49±66 strain, while a constitutively
Strikingly, the ability to activate Fus3 strictly correlatedactive form of Ste11 (encoded by STE11-4; Stevenson
with the ability of Ste5 to enter the nucleus, which inet al., 1992) did restore mating (Figure 4F). Ste5D49±66
turn correlated with the severity of the mutations acrosscould act as a scaffold and stimulate the activity of
the nuclear localization sequence (Figure 5E). TheseSte11-4 as well as wild-type Ste5 based on Fus1-lacZ
findings also strongly support the hypothesis that nu-activity (Figure 4G, 2a F), but it could not respond to a
clear shuttling of Ste5 is linked to activation of the matingfactor, as shown by no further increase in Fus1-lacZ
MAPK cascade.activity (Figure 4G, 1 a F) or G1 arrest (Figure 4H). Thus,
in vivo Ste5D49±66 is blocked at the Gb step of the
The Nuclear Pool of Ste5 Translocatespathway but still facilitates signal transmission from
to the Plasma MembraneSte11 to Fus3.
To gain more definitive evidence that the nuclear pool
of Ste5 translocates to the plasma membrane in theSte5D49±66 Is Unable to Localize to Gb
presence of a factor, we created a strain in which theat the Cell Periphery In Vivo
cytoplasmic pool of Ste5 originated from the nucleus.We therefore determined whether Ste5D49±66 could lo-
calize to Gb at the cell periphery. As shown in Figure A GAL1-TAgNLS-STE5-MYC9 gene was introduced into a
Cell
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Figure 4. Ste5D49±66 Is Blocked at the Gb Step of the Pathway but Can Bind Gb (Ste4), Ste11, Ste7, Fus3, and Ste5
(A) Gb (Ste4). S36 (ste4D ste5D) with GAL1p-HA-STE4 (pYEE181) and either STE5-MYC9 CEN (lanes 1, 3±5) or ste5D49±66-MYC9 CEN
(lanes 2, 6, and 7) was grown in 2% galactose media for 2 hr to induce expression of HA-Ste4, then in 2% dextrose media for 1 hr to
repress expression. HA-Ste4 was immunoprecipitated and detected as described (Feng et al., 1998), and Ste5-Myc9 was detected with
9E10.
(B) Ste11. Ste5-Myc9 was immunoprecipitated from extracts of strain EY1775 (ste5D) harboring a STE11 2m plasmid (pJD11) and either STE5
CEN (-tag), STE5-MYC9 CEN, or ste5D49±66-MYC9 CEN. Immunoblots were probed with anti-Ste11 rabbit polyclonal antibody and then
reprobed with 9E10.
(C) Ste7. Immunoprecipitations were done as in (B) except the strain harbored a STE7 2m plasmid (pSTE7.4) and Ste7 was detected with a
rabbit polyclonal anti-Ste7 antibody.
(D) Fus3. Fus3-HA was immunoprecipitated from extracts of strain EY1774 (ste5D fus3D) harboring FUS3-HA CEN (pYEE1102) or FUS3 CEN
(pYEE1100) and either CEN (YCplac33, -tag), STE5-MYC9 CEN, or ste5D49±66-MYC9 CEN as described (Kranz et al., 1994).
(E) Ste5. GST-Ste5 was purified and tested for the presence of Ste5-Myc9 as described (Feng et al., 1998). EY1775 (ste5D) harbored either
GAL1p-GST-STE5 (lanes 1±4) or GAL1p-GST (lanes 5±8) with either STE5-MYC9 CEN (lanes 1 and 5); STE5-MYC9 2m (lanes 2 and 6), ste5D49±66-
MYC9 CEN (lanes 3 and 7), or ste5D49±66-MYC9 2m (lanes 4 and 8).
(F) ste5D49±66 is blocked at the Gb step of the pathway. EY1775 (ste5D) containing ste5D49±66 CEN and either STE5 CEN, GAL1-STE4 CEN,
GAL1-STE50 CEN, or GAL1-STE20 CEN, and S-34 (STE11±4 ste5D) containing either STE5 CEN or ste5D49±66 CEN were assayed for mating
with MATa strain EY492.
(G and H) Ste5D49±66 activates Ste11±4 to normal basal levels.
S-34 strains in (F) were assayed for Fus1-lacZ activity and G1 arrest as described (Feng et al., 1998).
MATa nsp1ts strain with a conditional defect that blocks its expression was repressed and cells were incubated
at 378C to inactivate Nsp1 (Figure 6B). TAgNLS-Ste5-Myc9protein import (Nehrbass et al., 1993), but not protein
export (Kaffman et al., 1998). We reasoned that the nsp1ts gradually accumulated in the cytoplasm after 3 hr at
378C, indicating that its constitutive export was nomutation should block import of TAgNLS-Ste5, because
inactivation of Nsp1 blocks import of TAgNLS (Schlen- longer being counteracted by efficient reimport. Strik-
ingly, the nuclear derived TAgNLS-Ste5-Myc9 localizedstedt et al., 1993) by the importin a/b receptor (Gorlich,
1998; Pemberton et al., 1998), and we found that Ste5 to the plasma membrane in the presence of a factor,
arguing that Ste5 that is normally recruited to the plasmaalso required importin b for its import (Figure 6A). TAgNLS-
Ste5-Myc9 was induced at permissive temperature, then membrane originates from the nucleus.
Ste5 Travels through the Nucleus to Get to Gb
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Figure 5. Activation of the Mating MAPK Cascade Correlates with Transit of Ste5 through the Nucleus
(A) Localization of GFP-Ste5-CTM and GFP-Ste5D49±66-CTM in PPY858 (ste5D) and PAY20 (ste21D). Cells were grown for 3 hr in 2% galactose
media. Seventy-nine percent of GFP-Ste5D49±66-CTM cells formed projections compared to 84% of GFP-STE5-CTM cells.
(B) GFP-Ste5D49±66-CTM activates FUS1-lacZ. PPY858 (ste5::ADE2 FUS1::FUS1-LacZ::LEU2) with either GAL1-GFP-STE5-CTM (pPH-GS5-
CTM) or GAL1-GFP-ste5D49±66-CTM was grown in 2% galactose 1 0.1% dextrose, and Fus1-lacZ activity was measured as described
(Pryciak and Huntress, 1998).
(C and D) Coexpression of TAgNLS-Ste5 with Ste5D49±66 does not bypass the block in G1 arrest or FUS1 expression. G1 arrest and Fus1-
lacZ activity were assayed in PPY858 (ste5D FUS1::FUS1-lacZ::LEU2) containing either CEN (YCplac33) 1 CEN (B1817), STE5 CEN (pYBS138) 1
CEN (B1817), TAgNLS-STE5 CEN (pSKM44) 1 CEN (B1817), CEN (YCplac33) 1 ste5D49±66 CEN (pSKM93), or TAgNLS-STE5 CEN (pSKM44) 1
ste5D49±66 CEN (pSKM93) using 5 ml of 0.1 mM a factor for the halo assays and 1.5 hr induction with 2 mM a factor for Fus1-lacZ assays.
(E) The abilities of Ste5 to enter the nucleus and activate Fus3 correlate. Fus3-HA kinase assays of extracts from EY1774 (ste5D fus3D) containing
FUS3-HA CEN and either STE5 CEN, ste5D49±66 CEN, ste5A49,50 CEN, ste5A64±66 CEN, or ste5A49,50A64±66 CEN. Plus sign indicates 50 nM
a factor for 60 min. Nuclear entry was assessed by counting the number of G1 phase nuclei that showed nuclear appearance of wild-type and
mutant Ste5-Myc9 expressed from 2m plasmids. G1 phase cells nuclei were identified by costaining with DAPI and YOL1/34 to detect microtubules.
Enhanced Transit of Ste5 through the Nucleus 15 min a factor treatment, compared to 3% of the Ste5-
Myc9 cells (Figure 7A). TAgNLSK128T-Ste5-Myc9 also hy-Stimulates Pathway Activation
We also sought to determine whether increasing the perinduced FUS1 expression and G1 arrest when ex-
pressed from a centromeric plasmid (Figures 7B andfraction of cytoplasmic Ste5 that shuttles through the
nucleus increases pathway activity. We added an enfee- 7C). These findings substantiate a model in which nu-
clear transit activates Ste5 for both plasma membranebled TAgNLSK128T sequence (which reduces, but does not
abolish, TAgNLS function; Kalderon et al., 1984) to the recruitment and pathway activation.
amino terminus of Ste5, in order to allow a greater pool
of exported Ste5 to accumulate in the cytoplasm com- Discussion
pared to TAgNLS-Ste5. More TAgNLSK128T-Ste5-Myc9 was
nuclear compared to Ste5-Myc9, but more of TAgNLSK128T- The Cytoplasmic Pool of Ste5 Is Inactive Unless
It Transits the NucleusSte5-Myc9 was cytoplasmic compared to TAgNLS-Ste5-
Myc9 (albeit much less than that of Ste5-Myc9; Figure Many lines of evidence lead us to propose that Ste5
shuttles through the nucleus in order to be competent7A, 2a F). Remarkably, TAgNLSK128T-Ste5-Myc9 induced
constitutive cell enlargement and shmoo-like morpho- to localize to the Gb subunit Ste4 at the plasma mem-
brane and activate the mating MAPK cascade (Figuregenesis, and 50% of the TAgNLSK128T-Ste5-Myc9 cells dis-
played obvious plasma membrane recruitment after a 7D). First, recruitment of Ste5 to the plasma membrane
Cell
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Figure 6. Nuclear Ste5 Translocates to the Plasma Membrane in the Presence of a Factor
(A) Nuclear import of Ste5 is regulated by Rsl1/Kap95/b-importin. Localization of Ste5-Myc9 (expressed from a 2m plasmid) in wild-type (RYL1)
and rsl1-4 (PSY1103) and pse1-1 (PSY1201) mutants (Seedorf and Silver, 1997) after incubation at 378C for 3 hr.
(B) TAgNLS-Ste5 accumulates in the cytoplasm and translocates to the cell periphery when its import is blocked by nsp1ts. MATa nsp1ts (LDY375)
harboring GAL1-TAgNLS-STE5 CEN was grown to midlogarithmic phase in raffinose medium at room temperature, shifted to galactose medium
for 2 hr, then to glucose medium for 1 hr, then transferred to 378C glucose medium for 3 hr. TAgNLS-Ste5-Myc9 was immunolocalized at the
indicated times.
is rapid and requires binding to Gb. Second, a pool no correlation between the ability of Ste5 to enter the
nucleus and perform the most obvious possible nuclearof Ste5 shuttles through the nucleus during vegetative
growth and undergoes enhanced export from the nu- function: transcriptional activation of Ste12-dependent
genes.cleus to the cytoplasm in the presence of a factor as
part of a rapid signaling event. Third, the nuclear pool We therefore conclude that transit of Ste5 through
the nucleus must impart a modification that allows Ste5of Ste5 translocates to the plasma membrane in the
presence of a factor. to localize to Gb. Possible means of modifying Ste5
include phosphorylation/dephosphorylation, the addi-Strong support for the model comes from the behav-
ior of mutant Ste5 proteins that have altered abilities tion of a membrane targeting sequence, or access to a
targeting protein. Nuclear import or export sequencesto transit the nucleus. First, a mutant Ste5 protein
(Ste5D49±66) that is restricted to the cytoplasm and within Ste5 could also be directly involved in recruitment
to Gb.excluded from the nucleus is completely unable to trans-
mit the pheromone signal from Gb, even in cells con-
taining nuclear-localized Ste5. The signaling defect of
Ste5D49±66 is due to its inability to localize to Gb at the Does Localization of Ste5 to the Cell Periphery
Involve a Sorting Pathway from the Nucleus?cell periphery, rather than an intrinsic defect in its ability
to bind signaling components and transmit the signal Our results suggest that Ste5 localizes to the cell periph-
ery via a sorting pathway that originates at the nucleus.from Ste20 to the MAPKs. Second, Ste5 point mutations
across a sequence required for nuclear import demon- Ste5 membrane recruitment is only detected in unbud-
ded cells and at the tips of mating projections, stronglystrate a strict correlation between the ability of Ste5 to
transit the nucleus and activate Fus3. Third, increasing arguing that it involves a polarized sorting mechanism.
During mating, yeast cells undergo polarized growththe amount of Ste5 that transits through the nucleus
increases its ability to be recruited to the plasma mem- toward their mating partner by sensing a pheromone
gradient (Segall, 1993). The polarized growth involvesbrane and activate the pathway. By contrast, there is
Ste5 Travels through the Nucleus to Get to Gb
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Figure 7. TAgNLSK128T Enhances Ste5 Plasma Membrane Recruitment and Pathway Activation
(A) Localization of Ste5-Myc9, TAgNLS-Ste5-Myc9, and TAgNLSK128T-Ste5-Myc9. Ste5-Myc9 constructs were expressed from 2m plasmids in EY1775 6
50 nM a factor for 15 min.
(B and C) TAgNLSK128T-Ste5-Myc9 increases Fus1-lacZ activity and a factor sensitivity. EY1775 harbors STE5-MYC9 CEN, TAgNLS-STE5-MYC9
CEN, or TAgNLSK128T-STE5-MYC9 CEN. Plus sign indicates 50 nM a factor for 1.5 hr.
(D) Model for the localization of Ste5 to the plasma membrane. See text for details. The asterisk indicates that Ste5 is competent to localize
at the plasma membrane.
(E) Ste11-Myc is excluded from the nucleus. EY706 1 GAL1p-STE11M (pNC245, Rhodes et al., 1990) was grown for 4 hr in 2% galactose
media.
the actin cytoskeleton and polarized movement of se- possibility. Bem1 also associates with Far1 (Lyons et al.,
cretory vesicles that emanate from the ER that is contig- 1996), the CDKI that also regulates growth orientation
uous with the nuclear envelope (Kaiser et al., 1997), (Dorer et al., 1995; Valtz et al., 1995), in a complex with
while microtubules emanating from the nucleus allow Cdc24, Cdc42, and Ste4 (Butty et al., 1998; Nern and
nuclear migration to the cell cortex (Marsh and Rose, Arkowitz, 1999). Far1 may also be localized to the cell
1997). Thus, asymmetric recruitment of Ste5 to the cell periphery by a similar mechanism as Ste5, because Far1
cortex may involve components of the cytoskeletal and/ binds to Ste4 (Butty et al., 1998), has a RING-H2 domain
or secretory machinery that intersect with the nucleus. like that of Ste5 (Lyons et al, 1996), is nuclear during
The small pool of Ste5 we detect at the cell periphery vegetative growth, and is cytoplasmic in the presence
is unlikely to be responsible for all of the signal transmis- of pheromone (Butty et al., 1998). Assessment of Far1
sion, because both budded and unbudded cells respond localization at native levels may be required to detect
to mating pheromone. Thus, it seems likely that we have such recruitment.
detected only a part of the total recruitment that takes
place, perhaps because of masking by the cytoplasmic
Regulating Access of the Cytoplasmic Pool of Ste5pool. The pool we do detect may reflect an enhanced
to the Plasma Membrane May Be Importantrecruitment that is required to sustain pathway activa-
for Maintaining Pathway Specificitytion as well as other mating functions, since it is also
Our results raise the obvious question of why yeast cellsdetected at the projection tip. Ste5 associates with
would go to so much trouble to shuttle a protein throughBem1 (Lyons et al., 1996), an actin-associated protein
the nucleus if its functions are predominantly cyto-(Leeuw et al., 1995) that regulates polarized growth dur-
ing mating (Chenevert et al., 1992), in support of this plasmic. We suggest that nuclear shuttling may allow
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al., 1998). pSKM32: ste5D49±66 URA3 CEN. PCR-generated deletionSte5 to be maintained in the cytoplasm in an inactive
using oligos CM1 59CATCTAGCATCCGCGCT and SKM35 59CGCGCstate prior to pheromone induction, because unregu-
CCGGGGATTCTCACCTTCT; SKM36 59 CGCGCCCGGGCTCTTGAlated recruitment of Ste5 to the plasma membrane would
CAATGGGG and SKM17 59-TAGCGCACGAACGTCT. pSKM39:
activate the pathway, possibly by juxtaposing Ste11 to ste5DK49±66-MYC9 URA3 2m. pSKM42: ste5DK49±66-MYC9 URA3
Ste20, which is at the cell periphery, through its contacts CEN. pSKM44: TAgNLS-STE5 URA3 CEN. TAgNLS BamHI-BamHI PCR
fragment in pSKM10 BamHI site (oligos SKM29 59-CGCGGGATCwith Cdc42 (Peter et al., 1996; Leberer et al., 1997). This
CAATTCAAAATG and SKM30 and template ZM112). pSKM50: STE5-view is suggested by the fact that artificially targeting
MYC9 TRP1 2m. pSKM69, pSKM70, and pSKM75: K49, K50, K64,Ste5 to the plasma membrane activates the pathway
K65, and K66 of STE5 were changed to alanine by PCR mutagenesisin a Ste20-dependent manner (Pryciak and Huntress,
(Sarkar and Sommer, 1990) using pSKM24 as template and two
1998), and that at high enough levels, Ste5 activates pairs of primers (oligos SKM44 59-ATTGTCAAGAGGCGCCGCATGG
Ste11 in the absence of pheromone (Choi et al., 1994). ACGGAAAAG and SKM45 59 CTTTTCCGTCCATGCGGCGCCTCTTG
ACAAT for A49A50; SKM46 59-CAAAGAAGTAGTGCTG CCGCGGCAIn vegetatively growing cells, Ste11 localizes in the cyto-
AGATTCTCACCTTCT and SKM47 59-AGAAGGTGAGAATCTTGCCGplasm and appears to be excluded from the nucleus
CGGCAGCACTACTTCTTTG for A64A65A66) and subcloning the(Figure 7E), supporting the possibility that its activation
fragments into BamHI-AflII sites of pSKM10 to generate pSKM69requires a pool of Ste5 that has shuttled through the
and pSK70, respectively. pSKM75 with K49, K50, K64, K65, and K66
nucleus. Because Ste11, Ste7, and Kss1 participate in changed to alanines was generated by using pSKM70 as a template
other signal transduction pathways, it may also be im- and oligos SKM44 and SKM47. pSKM71, pSKM73, and pSKM76:
MYC9 derivatives of the ste5 mutants in pSKM69, pSKM70, andportant that an inactive form of Ste5 sequesters the
pSKM75, respectively. pSKM78: GAL1p-STE50 LEU2 CEN. STE50kinases to prevent cross-talk. Consistent with this, bio-
BamHI-SphI PCR fragment in pZM44 BamHI-SphI sites usingchemical and genetic experiments argue that Ste5 se-
oligos SKM49 59-GCGCGGATCCATGGAGGACGGTAAACAG andquesters Ste11, Ste7, and Fus3 prior to pheromone in-
SKM50 59-GCGCGCCATGCTTAGAGTCTTCCACCGGG and template
duction (Choi et al., 1994; Kranz et al., 1994; Yashar et pMG5. pSKM84: CUP1p-ste5D49±66-MYC9 URA3 CEN. pSKM88:
al., 1995; Lee and Elion, submitted). Further work will ste5C180A CEN URA3. pSKM90: STE5-MYC9 HIS3 2m. pSKM91:
ste5D49±66-MYC9 HIS3 2m. pSKM92: STE5-MYC9 HIS3 CEN.determine whether nuclear shuttling of Ste5 represents
pSKM93: ste5D49±66-MYC9 HIS3 CEN. GAL1p-GFP-ste5D49±66-a general strategy that cells use to regulate the activity
CTM: the 59 noncoding KpnI site of GAL1p-GFP-GS5-CTM (gift ofof cytoplasmic proteins, similar to that of cytoplasmic
P. Pryciak) was filled in and the AflII-KpnI fragment was replacedretention for proteins with nuclear functions (Blank et
with that of pSKM42.
al., 1992; Wen et al., 1995; Brunet et al., 1999; Lopez-
Girona et al., 1999). Pheromone Response Assays
Halo assays were done as described (Elion et al., 1990) using 5 ml
of 100 mM a factor (in 90% methanol) for bar1 strains. Strains wereExperimental Procedures
mated as described (Elion et al., 1990). Percentages of unbudded
cells and shmoos were tallied after a 3 hr exposure to a factorYeast Strains and Plasmids
as described (Farley et al., 1999). FUS1 transcription was assayedAll yeast strains are isogenic derivatives of W303a and previously
with FUS1-lacZ reporter genes maintained either on a 2m plasmiddescribed. Yeast strains were grown using standard media and
(pJB207) or integrated (PPY858, Pryciak and Huntress, 1998).transformation techniques (Guthrie and Fink, 1991). Mutants were
b-galactosidase activity was quantitated as described (Farley et al.,verified by DNA sequencing by the Biopolymer Facility (Department
1999). Cells harboring GAL1-driven genes were grown to an A600 ofof Genetics, Harvard Medical School, Boston, MA).
0.6±0.8 in selective SC media with 2% raffinose, then diluted into
galactose medium to an A600 of 0.2 and grown for 5 hr at 308C.Plasmids
pSKM6: STE5 CEN URA3. pSKM9: STE5 CEN URA3 with the poly-
Visualization of Ste5linker SalI site filled in and the BamHI site prior to the STE5 stop
Indirect immunofluorescence was performed as described (Pringle(TAT) codon, introduced by two-step PCR and subcloning of SalI-
et al., 1991). Cells were fixed with 5% formaldehyde for 1 hr at roomBamHI; and BamHI-SacI PCR fragments generated with oligos
temperature and spheroplasted for 30 min at 308C in solution B 1SKM12 59CGCGGGATCCTAGAGTATACACTAAATT and SKM13 59
100 mg/ml Lyticase (Sigma), 3 mg/ml phenyl methyl sulfonyl fluoride,CCAGTCACGACGTTGTA; SKM11 59 CGCGGGATCCTATATAATC
2 ml/ml of b-mercaptoethanol. Cells were either fixed in 2208C meth-CATATGGAG and SKM20 59 TGCACGATAATGATACTGT. pSKM10:
anol for 5 min followed by 30 s in 2208C acetone for indirect immuno-STE5 CEN URA3 with a BamHI site at the STE5 start (ATG) codon
fluorescence or stained directly with phalloidin to verify the integrityusing two-step PCR and subcloning of XbaI-BamHI and BamHI-AflII
of the actin cytoskeleton. 9E10 (1:50 dilution of ascites fluid) andPCR fragments generated with oligos SKM14 59CGCGGGATCCTTA
YOL1/34 (1:500 dilution of antibody; Accurate Inc., Westbury, NY)AAAGTTGTTTCCGCTGTA and SKM15 59AGCTATGACCATGATTAC;
were used with DichloroTriazinyl Amino Fluorescein (DTAF)-conju-SKM16 59CGCGGGATCCATGATGGAAACTCCTACA and SKM17
gated secondary antibody and CY3-conjugated secondary antibody59TAGCGCACGAACGTCT. pSKM12: STE5-MYC9 URA3 CEN. pSKM9
(Jackson Immuno Research).with nine tandem copies of the c-MYC epitope in the 39-BamHI site.
pSKM14: CUP1p-STE5 URA3 CEN. pSKM17: CUP1p-STE5-MYC9
URA3 CEN. pSKM19: STE5-MYC9 2m URA3. pSKM20: STE5 2m Kinase Assays and Coimmunoprecipitations
Strains were grown and induced with 50 nM a factor as describedURA3. pSKM21: CUP1p-GFP-STE5 URA3 CEN. Superglow GFP
(Kahana et al., 1995) is inserted into pSKM14 BamHI site using (Elion et al., 1993; Feng et al., 1998). Kinase assays and immunopre-
cipitations were done exactly as described (Elion et al., 1993; KranzPCR oligos SKM23 59-GCGCGGATCCCTCGAGATGGCTAGCAAAG
GAG and SKM24 59-TCGGGCTTTGTTAGCAG. pSKM22: STE5-GFP et al., 1994) except that the modified H buffer contained 100 mM
NaCl and 10 mM benzimidine, using 250 mg to 5 mg of whole cellURA3 CEN. The GFP PCR fragment is inserted into the BamHI site
of pSKM9. pSKM23: GFP-STE5 URA3 CEN. The GFP PCR fragment extract with either 3 mg 12CA5, 1 mg of 9E10, or 30 ml of glutathione-
Sepharose beads (Sigma) in a 0.8±1.0 ml final volume. Immunoblotis inserted into the BamHI site of pSKM10. pSKM27: GAL1p-TAgNLS-
STE5 CEN URA3. Has GAL1-10p-TAgNLS PCR fragment (encoding analysis was performed as described (Kranz et al., 1994) using
1:25,000 dilution of monoclonal 9E10 and 12CA5 or 1:1000 dilutionMPKKKRKVHMGS) inserted into pSKM10 (oligos SKM33 59CGCGT
CTAGAGGG CCCCATCGA and SKM30 59CGCGGGATCCGGGCCC of anti-Ste11 and anti-Ste7 rabbit antiserum (gift of B. Cairns) or
rabbit anti-GST antiserum (Lyons et al., 1996) and the ECL systemCATCG and template pZM253). pSKM29: GAL1p-TAgNLS-STE5-
MYC9 URA3 CEN. pSKM31: STE5C180A-MYC9 2m URA3 (Feng et (Amersham, Arlington Heights, IL).
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